Deletion of cytosolic phospholipase A2 promotes striated muscle growth

Nature Medicine

Volumn 9, Issue 7, 2003, Pages 944-951

  Haq, Syed ^a   Kilter, Heiko ^a   Michael, Ashour ^a   Tao, Jingzang ^b   O'Leary, Eileen ^b   Sun, Xio Ming ^b   Walters, Brian ^a   Bhattacharya, Kausik ^a   Chen, Xin ^a   Cui, Lei ^c   Andreucci, Michele ^b,f   Rosenzweig, Anthony ^b   Guerrero, J Luis ^b   Patten, Richard ^a   Liao, Ronglih ^c   Molkentin, Jeffery ^d   Picard, Michael ^b   Bonventrel, Joseph V ^e   Force, Thomas ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE A2; PROTEIN KINASE C ALPHA; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CYTOSOL; ECHOCARDIOGRAPHY; GENE DELETION; GROWTH REGULATION; HEART HYPERTROPHY; HOMEOSTASIS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INFLAMMATION; MESANGIUM CELL; MOUSE; MUSCLE GROWTH; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKELETAL MUSCLE; STRESS;

ANIMALS; ARACHIDONIC ACID; CARDIOMEGALY; CELLS, CULTURED; CYTOSOL; FEMALE; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, MUTANT STRAINS; MUSCLE, SKELETAL; ORGAN SIZE; PHOSPHOLIPASES A; PHOSPHOPROTEINS; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0038379171     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm891     Document Type: Article

References (45)

1. 2. J. Biol. Chem. 272, 16069-16072 (1997).
2. 2. J. Biol. Chem. 272, 16709-16712 (1997).
3. 2. Nature 390, 622-625 (1997).
4. 2 in allergic response and parturition. Nature 390, 618-622 (1997).
5. 2 gene. J. Biol. Chem. 275, 34013-34016 (2000).
6. min-induced tumorigenesis. Proc. Nat. Acad. Sci. USA. 98, 3935-3939 (2000).
7. Kunapuli, P., Lawson, J.A., Rokach, J.A., Meinkoth, J.L. & Fitzgerald, G.A. Prostaglandin F2α and the isoprostane, 8,12-iso-Isoprostane F2α-III, induce cardiomyocyte hypertrophy. J. Biol. Chem. 273, 22442-22452 (1998).
8. Lai, J. et al. Prostaglandin F2 alpha induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo. Am. J. Physiol. 271, H2197-H2208 (1996).
9. Shima, H. et al. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J. 17, 6649-6659 (1998).
10. Shioi, T. et al. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 19, 2537-2548 (2000).
11. Weinkove, D. & Leevers, S.J. The genetic control of organ growth: insights from Drosophila. Curr. Opin. Genet. Dev. 10, 75-80 (2000).
12. Haq, S. et al. Glycogen synthase kinase-3β is a negative regulator of cardiomyocyte hypertrophy. J. Cell. Biol. 151, 117-129 (2000).
13. Crackower, M.A. et al. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 110, 737-749 (2002).
14. Lupu, F., Terwilliger, J.D., Lee, K., Segre, G.V. & Efstratiadis, A. Roles of growth hormone and IGF-1 in mouse postnatal growth. Dev. Biol. 229, 141-162 (2001).
15. Cittadini, A. et al. Importance of an intact growth hormone/IGF-1 axis for normal post-infarction healing: studies in dwarf rats. Endocrinology 142, 332-338 (2001).
16. Haq, S. et al. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 103, 670-677 (2001).
17. Fazio, S., Palmieri, E.A., Biondi, B. & Sacca, L. The role of the GH-IGF-1 axis in the regulation of myocardial growth: from experimental models to human evidence. Eur. J. Endocrinol. 142, 211-216 (2000).
18. Duerr, R.L. et al. IGF-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J. Clin. Invest. 95, 619-627 (1995).
19. Musaro, A., McCullagh, K.J.A., Naya, F.J., Olson, E.N. & Rosenthal, N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400, 581-585 (1999).
20. Musaro, A. et al. Localized IGF-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 27, 195-200 (2001).
21. Pete, G. et al. Postnatal growth responses to insulin-like growth factor I in insulin receptor substrate-1-deficient mice. Endocrinology 140, 5478-5487 (1999).
22. Wang, J., Zhou, J., Powell-Braxton, L. & Bondy, C. Effects of Igf1 gene deletion on postnatal growth patterns. Endocrinology 140, 3391-3394 (1999).
23. Welch, S. et al. Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ. Res. 90, 641-648 (2002).
24. 2, induces apoptosis and potentiates prostaglandin production. Mol. Cell. Biol. 14, 4470-4481 (2001).
25. Ravichandran, L.V., Esposito, D.L., Chen, J. & Quon, M.J. Protein kinase C ζ phosphorylates insulin receptor substrate-1 and impairs its ability to activate PI3-K in response to insulin. J. Biol. Chem. 276, 3543-3549 (2001).
26. LeGood, J.A. et al. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281, 2042-2045 (1998).
27. Balendran, A., Hare, G.R., Kieloch, A., Williams, M.R. & Alessi, D.R. Further evidence that PDK1 is required for the stability and phosphorylation or protein kinase C (PKC) isoforms. FEBS Lett. 484, 217-223 (2000).
28. Williams, M.R. et al. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr. Biol. 10, 439-448 (2000).
29. Chou, M.M. et al. Regulation of protein kinase C zeta by PI 3-kinase and PDK-1. Curr. Biol. 19, 1069-1077 (1998).
30. Donohue, T.J. et al. Induction of myocardial IGF-1 gene expression in left ventricular hypertrophy. Circulation 89, 799-809 (1994).
31. Belke, D.D. et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J. Clin. Invest. 109, 629-639 (2002).
32. Shiojima, I. et al. Akt signaling mediates postnatal heart growth in response to insulin and nutritional status. J. Biol. Chem. 277, 37670-37677 (2002).
33. Bueno, O.F. et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 19, 6341-6350 (2000).
34. Fernandez, A.M. et al. Muscle-specific inactivation of the IGF-1 receptor induces compensatory hyperplasia in skeletal muscle. J. Clin. Invest. 109, 347-355 (2002).
35. Shioi, T. et al. Akt/Protein kinase B promotes organ growth in transgenic mice. Mol. Cell. Biol. 22, 2799-2809 (2002).
36. Rui, L. et al. Insulin/IGF-1 and TNFα stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J. Clin. Invest. 107, 181-189 (2001).
37. Liu, Y.F. et al. Insulin stimulates PKC-ζ -mediated phosphorylation of IRS-1. J. Biol. Chem. 276, 14459-14465 (2001).
38. Eldar-Finkelman, H. & Krebs, E.G. Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc. Nat. Acad. Sci. USA 94, 9660-9664 (1997).
39. VanHaesebroeck, B. & Alessi, D.R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346, 561-576 (2000).
40. Yang, J. et al. Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol. Cell 9, 1227-1240 (2002).
41. Balendran, A. et al. A 3-phosphoinositide-dependent protein kinase-1 (PDK1) docking site is required for the phosphorylation of protein kinase C ζ and PKC-related kinase 2 by PDK1. J. Biol. Chem. 275, 20806-20813 (2000).
42. Van der Hoeven, P.C.J., van der Wal, J.C.M., Ruurs, P. & van Blitterswijk, W.J. Protein kinase C activation by acidic proteins including 14-3-3. Biochem J. 347, 781-785 (2000).
43. He, T. C., et al. A simplified system for generating recombinant adenoviruses. Proc. Nat. Acad. Sci. USA 95, 2509-2514 (1998).
44. 2-terminal kinases. J. Clin. Invest. 104, 391-398 (1999).
45. Goruppi, S., Bonventre, J.V., & Kyriakis, J.M. Signaling pathways and late-onset gene induction associated with renal mesangial cell hypertrophy. EMBO J. 21, 5427-5436 (2002).